1. Sackstein R, Colten HR, Woods DE.  Phylogenetic conservation of a class III major histocompatibility complex antigen, factor B: isolation and nucleotide sequencing of mouse factor B cDNA clones.  J. Biol. Chem. 1983; 258:14693-14697.

2. Sackstein R, Colten HR.  Molecular regulation of MHC class III (C4 and factor B) gene expression in mouse peritoneal macrophages.  J. Immunol. 1984; 133:1618-1626.

3. Chaplin DD, Sackstein R, Perlmutter DH, Weis JH, Kruse TA, Coligan J, Colten HR, Seidman JG.  Expression of hemolytically active murine fourth component of complement in transfected L cells.  Cell 1984; 37:569-576.

4. Sackstein R, Roos MH, Demant P, Colten HR.  Subdivision of the mouse major histocompatibility complex by identification of genomic polymorphisms of the class III genes.  Immunogenetics 1984; 20:321-330.

5. Sackstein R, Falanga V, Streilein JW, Chin YH.  Lymphocyte adhesion to psoriatic dermal endothelium is mediated by a tissue-specific receptor/ligand interaction.  J. Invest Dermatol. 1988; 91:423-430.

6. Chin YH, Falanga V, Streilein JW, Sackstein R.  Specific lymphocyte-endothelial cell interactions regulate migration into lymph nodes, peyer's patches and skin.  Regional Immunology 1988; 1:78-83.

7. Chin YH, Falanga V, Streilein JW, Sackstein R.  Lymphocyte recognition of psoriatic endothelium: evidence for a tissue-specific receptor/ligand interaction.  J. Invest Dermatol. 1989; 93:82-87.

8. Chin YH, Sackstein R, Cai JP.  Lymphocyte homing receptors and preferential migration pathways.  Proc. Soc. Exp. Biol. and Med. 1991: 196:374-380.

9. Oxley SM, Sackstein R.  Detection of an L-selectin ligand on a hematopoietic progenitor cell line.  Blood 1994; 84:3299-3306.

10. Sackstein R, Borenstein M.  The effects of corticosteroids on lymphocyte recirculation in humans: analysis of the mechanism of impaired lymphocyte migration to lymph node following methylprednisolone administration.  J. Invest. Med. 1995; 43:68-77.

11.  Sackstein R, Meng, L, Xu XM, Chin YH.  Evidence of post-transcriptional regulation of L-selectin gene expression in rat lymphoid cells.  Immunology 1995; 85:198-204.

12.  Wasik MA, Sackstein R, Novick D, Butmarc JR, Vonderheld E, Kadin MD.  Cutaneous CD56+ large (T-) cell lymphoma associated with a high concentration of circulating IL-2.  Human Pathology 1996; 27:738-744.

13.  Sackstein R, Fu L, Allen KL.  A hematopoietic cell L-selectin ligand exhibits sulfate-independent binding activity.  Blood 1997; 89:2773-2781.

14.  Ballester OF, Tummala R, Janssen WE, Fields KK, Hiemenz JW, Goldstein SC, Perkins JB, Sullivan DM, Rosen R, Sackstein R, Zorsky P, Saez R, Elfenbein GJ.  High-dose chemotherapy and autologous peripheral blood stem cell transplantation in patients with multiple myeloma and renal insufficiency.  Bone Marrow Transplantation 1997, 20:653-656.

15.  Sykes M, Preffer F, McAfee S, Saidman SL, Weymouth D, Andrews D, Colby C, Sackstein R, Sachs DH and Sykes M.  Mixed lymphohematopoietic chimerism and graft-vs-lymphoma effects after non-myeloablative therapy and HLA-mismatched donor bone marrow transplantation.  Lancet  1999; 353:1755-1759. 

16.  Spitzer TR, Delmonico F, Tolkoff-Rubin N, McAfee S, Sackstein R, Saidman S, Colby C, Sykes M, Sachs DH, Cosimi AB.  Combined HLA-matched donor bone marrow and renal transplantation for multiple myeloma with end stage renal disease: The induction of allograft tolerance through mixed lymphohematopoietic chimerism.  Transplantation 1999; 68: 480-484.

17.  Toh HC, McAfee SL, Sackstein R, Cox BF, Colby C, Spitzer TR. Late-onset veno-occlusive disease following high dose chemotherapy and stem cell transplantation.  Bone Marrow Transplantation 1999; 24:891-895.

18.  Colby C, McAfee SL, Sackstein R, Finkelstein DM, Fishman JA, Spitzer TR.  A prospective randomized trial comparing the toxicity and safety of atovaquone with trimethoprim/sulfamethoxazole as Pneumocystis carinii pneumonia prophylaxis following autologous peripheral blood stem cell transplantation.  Bone Marrow Transplantation 1999; 24: 897-902.

19.  Salgia R, Quackenbush E, Lin J, Souchkova N, Sattler M, Ewaniuk DS, Klucher KM, Daley GQ, Kraeft SK, Sackstein R, Alyea EP, von Adrian UH, Chen LB, Gutierrez-Ramos J-C, Pendergast A-M, Griffin JD. The BCR/ABL oncogene alters the chemotactic response to Stromal-Derived Factor-1a.  Blood 1999; 94:4233-4246.

20.  Colby C, Chang Q, Fuchimoto Y, Ferrara V, Sackstein R, Spitzer TR, Scharf-White ME, Sachs DH. Cytokine-mobilized peripheral blood progenitor cells for allogeneic reconstitution of miniature swine. Transplantation  2000; 69:135-140.

21.  Toh HC, McAfee SL, Sackstein R, Multani P, Cox BF, Garcia-Carbonero R, Colby C, Spitzer TR.  High-dose cyclophosphamide + carboplatin and interleukin-2 (IL-2) activated autologous stem cell transplantation followed by maintenance IL-2 therapy in metastatic breast carcinoma – A phase II study.  Bone Marrow Transplantation 2000; 25:19-24.

22.  Buhler L, Awwad M, Basker M, Gojo S, Watts A, Treter S, Nash K, Oravec G, Chang Q, Thall A, Down J, Sykes M, Andrews D,  Sackstein R, White-Scharf M, Sachs DH, Cooper DKC.  High-dose porcine hematopoietic cell transplantation combined with CD40L blockade in baboons prevents an induced anti-pig humoral response.  Transplantation 2000; 69:2296-304.

23.  Spitzer TR, McAfee S, Sackstein R, Colby C, Toh HC, Multani P, Saidman S, Weymouth D, Preffer F, Poliquin C, Foley A, Cox B, Dombowski D, Andrews D, Sachs DH, Sykes M.  The intentional induction of mixed chimerism and achievement of anti-tumor responses following non-myeloablative conditioning therapy and HLA-matched and mismatched donor bone marrow transplantation for refractory hematologic malignancies.  Biology of Blood and Marrow Transplantation 2000; 6:309-320.

24. Sackstein R, Dimitroff CJ.  An hematopoietic cell L-selectin ligand that is distinct from PSGL-1 and displays N-glycan-dependent binding activity.  Blood 2000; 96:2765-2774.

25. Dimitroff CJ, Lee J, Fuhlbrigge RC, Sackstein R.  A distinct glycoform of CD44 is an L-selectin ligand on human hematopoietic progenitor cells.  Proc. Natl. Acad. Sci. USA 2000; 97:13841-13846.

26.  Buhler L, Basker M, Alwayn IPJ, Goepfert C, Kitamura H, Kawai T, Gojo S, Kozlowski T, Ierino FL, Awwad M, Sachs DH, Sackstein R, Robson SC, Cooper DKC.  Coagulation and thrombotic disorders associated with pig organ and hematopoietic cell transplantation in nonhuman primates. Transplantation 2000; 70:1323-1331.

27.  Bühler L, Goepfert C, Kitamura H, Alwayn IPJ, Basker M, Gojo S, Chang Q, Down JD, Tsai HM,  Sachs DH, Cooper DKC, Robson SC, Sackstein R. Porcine hematopoietic cell xenotransplantation in non-human primates is complicated by thrombotic microangiopathy.  Bone Marrow Transplantation  2001; 27:1227-1236.

28.  Alwayn IPJ, Buhler L, Appel JZ, Goepfert C, Csizmadia E, Correa L, Harper D, Kitamura H, Down JD, Awwad M,  Sackstein R, Cooper DKC, Robson SC.  Mechanisms of Thrombotic Microangiopathy Following Xenogeneic Hematopoietic Progenitor Cell Transplantation.  Transplantation  2001; 71:1601-1609.

29.  Dimitroff CJ, Lee JY, Rafii S, Fuhlbrigge RC, Sackstein R.  CD44 is a Major E-selectin Ligand on Human Hematopoietic Progenitor Cells.  J. Cell Biology 2001; 153: 1277-1286.

30.  Gonzalez S, Sackstein R, Anderson RR, Rajadhyaksha M.  Real-time evidence of in vivo leukocyte trafficking in human skin by reflectance confocal microscopy.  Journal of Investigative Dermatology  2001; 117:384-386.

31.  Dimitroff CJ, Lee JY, Schor KS, Sandmaier BM, Sackstein R.  Differential L-selectin Binding Activities of the Human Hematopoietic Cell L-selectin Ligands, HCELL and PSGL-1.  J. Biol. Chem.  (Published On-Line in October, 2001)  2001; 276:47623-631.

32.  Exley M, Tahir SMA, Cheng O, Shaulov A, Wang R-J, Joyce R, Avigan D, Sackstein R, Balk SP.  A Major Fraction of Human Bone  Marrow Lymphocytes are Th2-Like CD1d-reactive T Cells that can Suppress Mixed Lymphocyte Reactions.  J. Immunology  2001; 167:5531-34.

33.  Dey BR, McAfee S, Sackstein R, Colby C, Saidman S, Weymouth D, Poliquin C, Vanderklish J, Sachs DH, Sykes M, Spitzer TR.  Successful Allogeneic Stem Cell Transplantation with Nonmyeloablative Conditioning in Patients with Relapsed Hematologic Malignancy Following Autologous Stem Cell Transplantation.  Biol. Blood Marrow Transplantation  2001; 7:604-12.

34.  Buhler L, Awwad M, Down JD, Treter S, Chang Q, Ericsson T, Harper D, Kurilla-Mahon B, Alwayn IPJ, Basker M, Huang C, Sackstein R, Sykes M, White-Scharf ME, Sachs DH, Cooper DKC.  Pig hematopoietic cell chimerism in baboons conditioned with a nonmyeloablative regimen and CD154 blockade.  Transplantation  2002; 73:12-22.

35.  Fuhlbrigge R, King SL, Dimitroff CJ, Kupper TS, Sackstein R. Direct Real-time Observation of E- and P-selectin Mediated Rolling on Cutaneous Lymphocyte-Associated Antigen Immobilized on Western Blots.  J. Immunology 2002; 168: 5645-51.

36.  Theodore PR, Simon AR, Warren AN, Sackstein R, Sykes M.  Porcine Mononuclear Cells Adhere to Human Fibronectin Independently of VLA-5:  Implications for Donor-specific Tolerance Induction in Xenotransplantation.  Xenotransplantation  2002; 9:277-89.

37.  Buhler L, Kurilla-Mahon B, Chang Q, Abraham S, Alwayn IPJ, Appel JZ, Newman D, Awwad M, White-Scharf ME, Sackstein R, Sachs DH, Cooper DKC, Down JD.  Cryopreservation and Mycophenolate Therapy are Detrimental to Hematopoietic Progenitor Cells.  Transplantation 2002; 74:1159-1166.

38.  Buhler L, Spitzer TR, Sykes M, Sachs DH, Delmonico F, Rubin N, Saidman S, Sackstein R, McAfee S, Dey B, Colby C, Wemouth D, Cosimi AB.  Induction of Kidney Allograft Tolerance through Mixed Lymphohematopoietic Chimerism in Patients with Multiple Myeloma and End-stage Renal Disease.  Transplantation  2002; 74:1405-1409.

39.  Toh HC, Spitzer TR, Preffer F, Alexander SI, McAfee S, Dombowski D, Clark JS, Colby C, Saidman S, Sackstein R, Sykes M.  Fluctuating Lymphocyte Chimerism, Tolerance and Anti-tumor Response in a Patient with Refractory Lymphoma Receiving Non-myeloablative Conditioning and a Haploidentical Related Allogeneic Bone Marrow Transplant.  Cytokines Cell Mol Ther.  2002; 7:43-47.

40.  Sackstein R, Messina J, Elfenbein GJ.  In Vitro Adherence of Lymphocytes to Dermal Endothelium Under Shear Stress: Implications in Pathobiology and Steroid Therapy of Acute Cutaneous Graft versus Host Disease.  Blood 2003; 101:771-778.

41.  Dimitroff CJ, Bernacki RJ, Sackstein R.  Inhibition of Cutaneous Lymphocyte-Associated Antigen Expression: Implications in Modulating Lymphocyte Migration to Skin.  Blood 2003; 101:602-610.

42.  Dey BR, McAfee S, Colby C, Sackstein R, Saidman S, Tarbell N, Sachs DH, Sykes M, Spitzer TR.  The impact of prophylactic donor leukocyte infusions on mixed chimerism, graft-versus-host disease, and antitumor responses in patients with advanced hematologic malignancies treated with nonmyeloablative conditioning and allogeneic bone marrow transplantation.  Biol Blood Marrow Transplantation 2003; 9:320-329.

43.  Daly A, McAfee S, Dey B, Colby C, Schulte L, Yeap B, Sackstein R, Tarbell NJ, Sachs D, Sykes M, Spitzer TR.  Nonmyeloablative bone marrow transplantation: Infectious complications in 65 recipients of HLA-identical and mismatched transplants. Biol Blood Marrow Transplantation 2003; 9:373-82.

44.  Kraus AB, Shaffer J, Toh HC, Preffer F, Dombkowski D, Saidman S, Colby C, George R, McAfee S, Sackstein R, Dey B, Spitzer TR, Sykes M.  Early Host CD8 T-cell Recovery and Sensitized Anti-Donor IL-2-Producing and T Cell CTL Responses Associated with Marrow Graft Rejection Following Non-myeloablative Allegeneic Bone Marrow Transplantation.  Experimental Hematology 2003; 31:609-21.

45. Dimitroff CJ, Kupper TS, Sackstein R.  Prevention of Leukocyte Migration to Inflamed Skin with a Novel Fluorosugar Modifier of Cutaneous Lymphocyte-Associated Antigen. Journal of Clinical Investigation 2003; 112:1008-1018.

46. Milinkovic M, Antin JH, Hergrueter CA, Underhill CB, Sackstein R. CD44-Hyaluronic Acid Interactions Mediate Shear-resistant Binding of Lymphocytes to Dermal Endothelium in Acute GVHD. Blood 2004; 103: 740-742 (available on the Internet, 9/03).

47. Elfenbein GJ, Sackstein R, Oblon DJ. Do G-CSF mobilized, peripheral blood-derived stem cells from healthy, HLA-identical donors really engraft more rapidly than do G-CSF primed, bone marrow-derived stem cells?  Blood Cells, Molecules and Diseases 2004; 32: 106-111.

48. Elfenbein GJ, Sackstein R.  Primed Marrow for Autologous and Allogeneic Transplantation: A New Perspective from Reviewing the Published Literature.  Exp. Hematology 2004; 32:327-339.

49. Dey BR, McAfee S, Colby C, Cieply K, Caron M, Saidman S, Preffer F, Shaffer J, Tarbell N, Sackstein R, Sachs D, Sykes M and Spitzer TR.  Anti-tumor Response Despite Loss of Donor Chimerism in Patients Treated with Nonmyeloablative Conditioning and Allogeneic Stem Cell Transplantation.  Br. J. Hematology 2005; 128:351-359.

50. Hanley WD, Burdick MM, Konstantopoulos K and Sackstein R.  CD44 on LS174T Colon Carcinoma Cells Possesses E-selectin Ligand Activity.  Cancer Res. 2005; 65:5812-5817.

51. Hanley WD, Napier SL, Burdick MB, Schnaar RL, Sackstein R and Konstantopoulos K.   Variant Isoforms of CD44 are P- and L-Selectin Ligands on Colon Carcinoma Cells.  FASEB Journal 2006; 20:337-339 (available on Internet, 12/05).

52. Fuhlbrigge RC, King SL, Sackstein R, Kupper TS. CD43 is a Ligand for E-selectin on CLA+ Human T Cells.  Blood 2006; 107:1421-1426 (available on Internet, 11/05). 

53. Burdick MM,  Chu  JT, Godar S, Sackstein R.  HCELL is the major E- and L-selectin ligand expressed on LS174T colon carcinoma cells. J. Biol. Chem. 2006; 281:13899-905.

54. Dagia NM, Gadhoum SZ, Knoblauch CA, Spencer JA, Zamiri P, Lin CP, Sackstein R.  G-CSF Induces E-selectin Ligand Expression On Human Myeloid Cells.  Nature Medicine 2006; 12:1185-1190.

55. Schreiber TS, Shinder V, Cain D, Alon R, Sackstein R.  Shear flow-dependent integration of apical and subendothelial chemokines in T cell transmigration: Implications for locomotion and the “multi-step paradigm”.  Blood 2007; 109:1383-88 (available on Internet, 10/06).

56. Parmar K, Vergilio J, Mauch P, Sackstein R and Down JD.  Spatial Distribution of Bone Marrow Hematopoietic Stem Cells According to a Hoechst Dye Diffusion Gradient and Hypoxia.  Proc. Natl. Acad. Sci. USA. 2007; 104: 5431-5438.

57. Shaulov A, Wang RJ, Joyce R, DeSilva T, Balk SP, Avignan D, Uhl L, Sackstein R and Exley MA.  Mobilized Peripheral Blood Progenitor Cell Product Contains Th-1-biased non-classical CD1d-reactive ‘NKT cells’.   2008, accepted, Experimental Hematology.

58. Resto V, Dagia N, Burdick M, Sackstein R. L-selectin Receptor/ligand Interactions Under Low Shear Stress: Implications for Lymphatic Metastasis. 2008, in revision, Journal of Biological Chemistry.

59. Sackstein R, Merzaban JS, Cain DW, Dagia NM, Spencer JA, Lin CP, Wohlgemuth R.  Ex Vivo Glycan Engineering of CD44 Programs Human Multipotent Stromal Cell Trafficking to Bone.  Published on-line, January 13, 2008,  Nature Medicine.

60. Dagia NM, Fuhlbrigge R, and Sackstein R. CD43 is an E-selectin Ligand on Human Hematopoietic Progenitor Cells.  2008, submitted.

61. Burdick MM, Chu JT, and Sackstein R. Characterization of HCELL-Specific Contributions to E- and L-selectin Ligand Activities of Human Hematopoietic Cells. 2008, submitted.

62. Gadhoum SZ and Sackstein R. CD15/Lewis x Expression in Human Myeloid Cell Differentiation is Regulated by Sialidase Activity.   2008, submitted.

Proceedings of Meetings:
1. Colten HR, Cole FS, Sackstein R, Auerbach HS.  Tissue and species-specific regulation of complement biosynthesis in mononuclear phagocytes.  In:  Mononuclear phagocytes (Proceedings of the Fourth Leiden Conference), Martinus Nijhoff Publishers, The Netherlands, 1985, pp. 147-58.

2. Sackstein R.  Effects of methylprednisolone administration on lymphocyte LECAM-1, CD44 and LFA-1 expression:  implications for steroid-induced lymphopenia.  Annals of NY Acad Sci.  1993, 696:417-419.

3.  Buhler L, Awwad M, Basker M, Gojo S, Thall A, Down JD, Sykes M, Andrews D,      Sackstein R, White-Scharf ME, Sachs DH, Cooper DK. A nonmyeloablative regimen with CD40L blockade leads to humoral and cellular hyporesponsiveness to pig hematopoietic cells in baboons. Transplant Proc. 2000, 32:1100.

4. Alwayn IP, Buhler L, Basker M, Goepfert C, Kawai T, Kozlowski T, Ierino F, Sachs DH,Sackstein R, Robson SC, Cooper DK. Coagulation/thrombotic disorders associated with      organ and cell xenotransplantation. Transplant Proc. 2000, 32:1099.

5. Gopfert C, Buhler L, Wise R, Basker M, Gojo S, Imai M, Alwayn I, Sachs DH, Sackstein R, Cooper DK, Robson SC. Von willebrand factor concentration, multimeric patterns, and cleaving protease activity in baboons undergoing xenogeneic peripheral blood stem cell transplantation. Transplant Proc. 2000, 32:990.

6. Sackstein R.  The Bone Marrow is Akin to Skin: HCELL and the Biology of Hematopoietic Stem Cell Homing.  J. Invest. Dermatology, Symposium Proceedings, 2004, 9:215-223.

Reviews and Educationally Relevant Publications:
1. Whitehead AS, Sackstein R.  Molecular biology of the human and mouse MHC class III genes:  Phylogenetic conservation, genetics and regulation of expression.  Immunological Reviews 1985, 87:185-208.

2. Sackstein R, Chin YH.  Mechanisms of lymphocyte migration to lymphoid tissues and inflammatory sites.  Clinical Immunology Newsletter 1988, 9:181-184.

3. Chin YH, Falanga V, Cai JP, Sackstein R.  Molecular mechanisms mediating leukocyte migration to skin.  In:  Advances in gene technology: the molecular biology of immune diseases, IRL Press, Oxford, U.K., 1990, pp. 170-73.

4. Sackstein R.  Physiologic migration of lymphocytes to lymph nodes following bone marrow transplantation:  Role in immune recovery.  Sem. in Oncology 1993, 20(5, Supp. 6):34-39.

5. Sackstein R.  Adoptive immunotherapy: the magic bullet of cancer therapy?  Cancer Control 1994, 1:64-68.

6. Sackstein R.  Disruption of lymphocyte homing to lymph nodes following bone marrow transplantation:  implications for immune reconstitution.  Clinical Immunology Newsletter 1995, 15:144-149.

7. Sackstein R.  The physiologic basis of steroid-induced immunosuppression:  effects on lymphocyte migration to lymph nodes.  J. Fla. Med. Assoc. 1995, 82:613-615.

8. Sackstein R.  Lymphocyte migration following bone marrow transplantation.  Ann. of NY Acad Sci. 1995, 770:177-188.

9. Sackstein R, Chao N.  Veno-occlusive disease of the liver following bone marrow transplantation.  In:  The kidney in liver disease, 4th Edition, (M. Epstein, Ed.), Hanley and Belfus, Philadelphia, 1996, pp. 167-178.

10. Sackstein R.  Expression of an L-selectin ligand on hematopoietic progenitor cells.  Acta Haematol. 1997, 97:22-28.

11. Spitzer, T.R., Sackstein, R. Graft-versus-Host Disease: Has any progress been made in the past decade? In:  Bone Marrow Transplantation (B. Bolwell, ed.), Humana Press, Totowa, N.J., 1999, pp. 229-248.

12. Janssen WE, Elfenbein GJ, Perkins JB, Partyka JF, Smiley RC, Ballester OF, Goldstein SC, Fields KK, Heimenz JW, Sackstein R, Zorsky PE. Final report of the first prospective, stratified, randomized trial comparing G-CSF primed bone marrow cells with G-CSF mobilized peripheral blood cells for pace of hematopoietic engraftment and disease free survival after high dose therapy and autotransplant.  In: Autologous Blood and Marrow Transplantation. (Dicke KA, Keating A, editors). Carden Jennings, Charlottesville, VA, 1999, pp. 580-598.

13. Spitzer TR, McAfee SL, Sackstein R, Colby C, Dey B, Saidman S, Preffer F, Sachs DH, Sykes M.  Mixed lymphohematopoietic chimerism and delayed donor leukocyte infusions following non-myeloablative conditioning and HLA-matched and mismatched donor bone marrow transplantation (BMT).  In: Autologous Bone Marrow Transplantation. (Dicke KA, Keating A, editors). Carden Jennings, Charlottesville, VA, 2001, pp. 321-330.

14. Dey BR, Colby C, Sackstein R, Saidman S, Tarbell N, Sachs DH, Sykes M, Spitzer TR.  Impact of prophylactic donor leukocyte infusions on mixed chimerism, graft-versus-host disease, and antitumor response in patients with advanced hematologic malignancies treated with a nonmyeloablative conditioning and allogeneic bone marrow transplantation. Blood and Marrow Transplantation Reviews, 2003, 13:10-12.

15. Sackstein R.  The Bone Marrow is Akin to Skin: HCELL and the Biology of Hematopoietic Stem Cell Homing.  J. Invest. Dermatology, 2004, 122:1061-1069.

16. Sackstein, R.  The Lymphocyte Homing Receptors: Gatekeepers of the Multistep Paradigm.  Current Opinion in Hematology, 2005, 12(6):444-450.

17. Sackstein, R., Fuhlbrigge, RC. The Blot Rolling Assay: A Method for Identifying Adhesion Molecules Mediating Binding Under Shear Flow.  In: Methods in Molecular Biology (S. Colgan, ed.), Humana Press, Totowa, N.J., 2006, pp. 217-226.

18. Sackstein, R. A Revision of Billingham’s Tenets: The Central Role of Lymphocyte Migration in Acute Graft-versus-Host Disease.  Biology of Blood and Marrow Transplantation, 2006, 12:2-8.

19. Spitzer, T.R., Sackstein, R. Graft-versus-Host Disease: New Perspectives on Pathobiology and Treatment. In:  Clinical Malignant Hematology (M. Sekeres, M. Kalacyio, B. Bolwell, eds.), McGraw-Hill Publishers, N.Y., 2007, pp. 1051-1062.

20. Sackstein, R., Fuhlbrigge R.  Western Blot Analysis of Adhesive Interactions Under Fluid Shear Conditions: The Blot Rolling Assay.  In: Methods in Cell Biology, in press, 2007.

Books and Monographs:
1. Sackstein R, Janssen WE, Elfenbein GJ. (editors).  Bone marrow transplantation:  foundations for the 21st century (Proceedings of the New York Academy of Sciences Conference, March, 1995).  Ann. of NY Acad. Sci., Volume 770, 1995.